According to the evidence, WNT released from metastatic prostate cancer cells can stimulate osteoblasts and promote tumor growth, while Dickkopf-1 (DKK1), which inhibits WNT signaling, can lead to osteolysis, particularly in the early stages of cancer development. Here, DKK1 is linked to prostate carcinoma.